Please assess the completion status of the following clinical trial:

Trial Title: The Effect of the MedSentry System on Medication Adherence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have successfully completed the Partners Connected Cardiac Care Program (CCCP)~* Take at least 3 and no more than 10 different daily medications (including both prescription and non-prescription/over the counter medications) to treat Heart Failure (HF) and other comorbid disorders.~* Take medications no more than 4 specified times each day (i.e. morning, afternoon, early evening, bedtime).~* The patient must be able to open a pill bottle independently.~* The patient must be able to sort and manage their own medications.~* Hospitalization within the last 24 months.~* Have a telephone or cell phone.~* Live in the greater Boston area.~* The patients must speak, read and write English.~* The patients must not be either vision or hearing impaired (i.e., unable to hear an alarm similar to a clock alarm or oven alarm).~* Patient must have an Massachusetts General Hospital (MGH) affiliated care provider.~Exclusion Criteria:~* Dementia or other conditions precluding the participant from providing informed consent or from learning to use the MedSentry pillbox.~* Home environment unsuitable for the MedSentry pillbox and other installed equipment.~* Awaiting revascularization, cardiac resynchronization or heart transplant.~* Patients with a coexisting terminal illness like cancer or Chronic Renal Failure (CRF) requiring dialysis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): Subjects will continue to receive usual medical care from their doctor(s).
- MedSentry System (Type: EXPERIMENTAL): Subjects will continue to receive usual medical care from their doctor(s). Subjects will use the MedSentry System and electronic pillbox, to manage their medications.

Based on this trial design, predict the completion outcome and termination type (if applicable).